Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Duffaud

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2014
Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG)F Duffaud, P Meeus, J B Bachet, et al.
Anti-Cancer Drugs|March 23, 2001
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group StudyF Duffaud, M E van der Burg, M Namer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
ESMO Open|February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)C Moreau-Bachelard, L Campion, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'P Schöffski, A Wozniak, S Stacchiotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
ESMO Open|August 17, 2024
Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcomaA Dufresne, S Pokras, A Meurgey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2023
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 yearsJ Y Blay, S Piperno-Neumann, S Watson, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2014
Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG)F Duffaud, P Meeus, J B Bachet, et al.
Anti-Cancer Drugs|March 23, 2001
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group StudyF Duffaud, M E van der Burg, M Namer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
ESMO Open|February 24, 2022
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)C Moreau-Bachelard, L Campion, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'P Schöffski, A Wozniak, S Stacchiotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 6, 2024
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapseJ-Y Blay, C Schiffler, O Bouché, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
ESMO Open|August 17, 2024
Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcomaA Dufresne, S Pokras, A Meurgey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) databaseS Salas, N Resseguier, J Y Blay, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2023
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 yearsJ Y Blay, S Piperno-Neumann, S Watson, et al.
Pageof 8